Not Signed In -
IGF-1 |
|
|
Clinical Trial: Norditropin in Insulin-like Growth Factor (IGF) Deficient Children
This study is no longer recruiting patients.
|
Purpose
A 12-month, safety and efficacy study of Norditropin in children with growth failure associated with a growth factor deficiency.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Dwarfism, Pituitary | Drug: Norditropin | Phase III |
MedlinePlus related topics: Bone Diseases; Dwarfism; Pituitary Disorders
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Further Study Details:
Expected Total Enrollment: 180
Study start: June 2003; Study completion: March 2006
Last follow-up: January 2006; Data entry closure: February 2006
Eligibility
Ages Eligible for Study: 3 Years - 13 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Age 3 to 13
Location Information
California
Los Angeles, California, 90027, United States
San Diego, California, 92123, United States
Stanford, California, 94305, United States
Florida
Tallahassee, Florida, 32308, United States
Tampa, Florida, 33607, United States
St. Petersburg, Florida, 33701, United States
Indiana
Indianapolis, Indiana, 46202, United States
Massachusetts
Boston, Massachusetts, 02115, United States
Worcester, Massachusetts, 01655, United States
Michigan
Kalamazoo, Michigan, 49008, United States
Minnesota
Minneapolis, Minnesota, 55416, United States
Missouri
Kansas City, Missouri, 64108, United States
New York
Buffalo, New York, 10422, United States
Bronx, New York, 10467, United States
Brooklyn, New York, 11219, United States
Ohio
Cincinnati, Ohio, 45229, United States
Akron, Ohio, 44308, United States
Oklahoma
Oklahoma City, Oklahoma, 731034, United States
Pennsylvania
Hershey, Pennsylvania, 17033, United States
Philadelphia, Pennsylvania, 19104, United States
Philadelphia, Pennsylvania, 19107, United States
Pittsburgh, Pennsylvania, 15213, United States
South Carolina
Columbia, South Carolina, 29203, United States
Texas
San Antonio, Texas, 78207, United States
Washington
Seattle, Washington, 98105, United States
Wisconsin
Milwaukee, Wisconsin, 53226, United States
More Information
Study ID Numbers: HGH-2147
Record last reviewed: March 2005
Last Updated: March 18, 2005
Record first received: February 1, 2005
ClinicalTrials.gov Identifier: NCT00102817
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: March 2005
Last Updated: March 18, 2005
Record first received: February 1, 2005
ClinicalTrials.gov Identifier: NCT00102817
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
email this page
print this page
bookmark this page
feedback on this page
